230 related articles for article (PubMed ID: 17477035)
41. Pegylated interferon alfa-2b (peg-intron) plus ribavirin (rebetol) in the treatment of chronic hepatitis C: a local experience.
Seow EL; Robert Ding PH
Med J Malaysia; 2005 Dec; 60(5):637-41. PubMed ID: 16515116
[TBL] [Abstract][Full Text] [Related]
42. [Comparison of therapeutic results between combination therapy of peginterferon alpha-2a plus ribavirin and interferon alpha-2b plus ribavirin according to treatment duration in patients with chronic hepatitis C].
Lee HJ; Eun JR; Choi JW; Kim KO; Moon HJ
Korean J Hepatol; 2008 Mar; 14(1):46-57. PubMed ID: 18367857
[TBL] [Abstract][Full Text] [Related]
43. Predictive value of early virological response to treatment with different interferon-based regimens plus ribavirin in patients with chronic hepatitis C.
Napoli N; Giannelli G; Parisi CV; Antonaci A; Maddalena G; Antonaci S
New Microbiol; 2005 Jan; 28(1):13-21. PubMed ID: 15782622
[TBL] [Abstract][Full Text] [Related]
44. Interstitial pneumonia recurrence during chronic hepatitis C treatment.
Renou C; Germain S; Harafa A; Martin S; Larroque O; Muller P; Bertrand JJ; Halfon P
Am J Gastroenterol; 2005 Jul; 100(7):1625-6. PubMed ID: 15984999
[No Abstract] [Full Text] [Related]
45. Peginterferon alpha-2b plus ribavirin vs interferon alpha-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients.
Crespo M; Sauleda S; Esteban JI; Juarez A; Ribera E; Andreu AL; Falco V; Quer J; Ocaña I; Ruiz I; Buti M; Pahissa A; Esteban R; Guardia J
J Viral Hepat; 2007 Apr; 14(4):228-38. PubMed ID: 17381714
[TBL] [Abstract][Full Text] [Related]
46. A comparison of the exponential decay slope between PEG-IFN alfa-2b/ribavirin and IFN alfa-2b/ribavirin combination therapy in patients with chronic hepatitis C genotype 1b infection and a high viral load.
Izumi N; Asahina Y; Kurosaki M; Uchihara M; Nishimura Y; Inoue K; Ueda K; Tsuchiya K; Hamano K; Itakura J; Miyake S
Intervirology; 2004; 47(2):102-7. PubMed ID: 15192274
[TBL] [Abstract][Full Text] [Related]
47. [Early virologic response in retherapy with pegylated interferon alpha-2B plus ribavirin in children with chronic hepatitis C].
Pawłowska M; Palewicz E; Halota W
Przegl Epidemiol; 2006; 60(1):71-7. PubMed ID: 16758742
[TBL] [Abstract][Full Text] [Related]
48. A randomized controlled trial of pegylated interferon alpha-2a (40 KD) or interferon alpha-2a plus ribavirin and amantadine vs interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C.
Mangia A; Ricci GL; Persico M; Minerva N; Carretta V; Bacca D; Cela M; Piattelli M; Annese M; Maio G; Conte D; Guadagnino V; Pazienza V; Festi D; Spirito F; Andriulli A
J Viral Hepat; 2005 May; 12(3):292-9. PubMed ID: 15850470
[TBL] [Abstract][Full Text] [Related]
49. A case of severe thrombocytopenia in a patient with chronic hepatitis C caused by a single administration of pegylated interferon α 2a subsequent to 48 weeks of pegylated interferon α 2b plus ribavirin therapy.
Kato H; Fujishiro T; Narita M
Intern Med; 2010; 49(16):1741-4. PubMed ID: 20720351
[TBL] [Abstract][Full Text] [Related]
50. Serum KL-6 level is elevated in chronic hepatitis C patients with combination therapy of pegylated interferon and ribavirin.
Arase Y; Ikeda K; Suzuki Y; Kobayashi M; Suzuki F; Akuta N; Sezaki H; Hosaka T; Yatsuji H; Kawamura Y; Kobayashi M; Kumada H
Intern Med; 2007; 46(15):1155-60. PubMed ID: 17675762
[TBL] [Abstract][Full Text] [Related]
51. Adult respiratory distress syndrome after treatment with pegylated interferon alpha-2a and ribavirin.
Vartany E; Caldwell CA; Trow TK
Heart Lung; 2008; 37(2):153-6. PubMed ID: 18371508
[TBL] [Abstract][Full Text] [Related]
52. Simultaneous occurrence of pleural effusion and interstitial pneumonitis after treatment with pegylated interferon for hepatitis C virus infection.
Ji F; Li Z; Xue H; Liu L; Deng H
South Med J; 2011 Feb; 104(2):140-2. PubMed ID: 21206334
[TBL] [Abstract][Full Text] [Related]
53. Pegylated interferon and ribavirin-induced interstitial pneumonitis with ARDS.
Abi-Nassif S; Mark EJ; Fogel RB; Hallisey RK
Chest; 2003 Jul; 124(1):406-10. PubMed ID: 12853555
[TBL] [Abstract][Full Text] [Related]
54. Hashimoto encephalopathy with pegylated interferon alfa-2b and ribavirin.
Deutsch M; Koskinas J; Tzannos K; Vassilopoulos D; Mailis A; Tolis G; Hadziyannis S
Ann Pharmacother; 2005 Oct; 39(10):1745-8. PubMed ID: 16159996
[TBL] [Abstract][Full Text] [Related]
55. Reversible alopecia universalis secondary to PEG-interferon alpha-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection.
Kartal ED; Alpat SN; Ozgunes I; Usluer G
Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):817-20. PubMed ID: 17700271
[TBL] [Abstract][Full Text] [Related]
56. Intracerebral hemorrhage in a patient receiving combination therapy of pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.
Nishiofuku M; Tsujimoto T; Matsumura Y; Toyohara M; Yoshiji H; Yamao J; Fukui H; Yoshikawa M
Intern Med; 2006; 45(7):483-4. PubMed ID: 16679707
[No Abstract] [Full Text] [Related]
57. Pegylated interferon induced interstitial pneumonitis in a patient with hepatitis C infection.
Torres-Macho J; Jara-Chinarro B; Suárez-Aliaga B; Gámez-Díez S; García-de-Casasola G; de-Cuenca-Morón B
Rev Esp Enferm Dig; 2010 Oct; 102(10):606-8. PubMed ID: 21039072
[TBL] [Abstract][Full Text] [Related]
58. Pure red-cell aplasia associated with pegylated interferon-alpha-2b plus ribavirin.
Miura Y; Kami M; Yotsuya R; Toda N; Komatsu T
Am J Hematol; 2008 Sep; 83(9):758-9. PubMed ID: 18615552
[No Abstract] [Full Text] [Related]
59. [Clinical features of interstitial pneumonitis due to interferon alpha therapy for chronic hepatitis C].
Ji FP; Li ZX; Deng H; Xue HA; Liu Y; Li M
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):667-70. PubMed ID: 19403391
[TBL] [Abstract][Full Text] [Related]
60. Cutaneous necrosis complicating the injection of pegylated interferon alpha-2b in a patient with chronic hepatitis C.
Rosina P; Girolomoni G
Acta Dermatovenerol Croat; 2008; 16(1):35-7. PubMed ID: 18358108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
